Bryce A. Kerlin: Albumin Regulates Both Fibrin Clot Structure and Its Susceptibility to Fibrinolysis
Bryce A. Kerlin, Professor of Pediatrics – Hematology at The Ohio State University, shared a post on LinkedIn:
“In the latest research from my lab, Amanda Waller, in a great collaboration with Alisa Wolberg’s lab, demonstrated that albumin regulates both fibrin clot structure and its susceptibility to fibrinolysis.
Many thanks to our now retired lab tech, Katelyn Wolfgang, former student, Zachary Stevenson, and Lori Holle for their assay skills at the bench! You guys made this project both possible and fun!!!”
Title: Hypoalbuminemia increases fibrin clot density and impairs fibrinolysis
Authors: Amanda P. Waller, Katelyn J. Wolfgang, Zachary S. Stevenson, Lori A. Holle, Alisa S. Wolberg, Bryce A. Kerlin
Our Journal of Thrombosis and Haemostasis (JTH) paper in press can be found here:
Stay informed with Hemostasis Today.
-
Feb 23, 2026, 15:59Ney Carter Borges: Antithrombotic Therapy in 2025 – A Precision-Based Pharmacologic Update
-
Feb 23, 2026, 15:54Alan Nurden: From Early Discoveries to New Therapeutic Advances in von Willebrand Disease
-
Feb 23, 2026, 15:52Gevorg Tamamyan: Albania’s Vision for the Future of Pediatric Oncology
-
Feb 23, 2026, 15:36Simon Senanu: The Peripheral Blood Smear as an Essential Diagnostic Tool in Modern Medicine
-
Feb 23, 2026, 15:32Cheng-Hock Toh: The Paradox of Hematology
-
Feb 23, 2026, 15:20Rabab Al Dawood: Moderating the Coagulation and Hemostasis Session at the ISLH 1st Joint Conference
-
Feb 23, 2026, 15:16Amira Khater: Key Updates on Pulmonary Embolism Management from AHA and ACC Guidelines
-
Feb 23, 2026, 14:45Stacey McGeown: Rare Disease Awareness Day at QUB Marks the Start of Rare Disease Month
-
Feb 23, 2026, 13:53Rare Diseases, Plasma-Derived Medicines and the Elephant in the Room – Part 1